LOBULAR BREAST CARCINOMA
Clinical trials for LOBULAR BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis study tested a combination of two drugs, crizotinib and fulvestrant, in 33 people with advanced lobular breast cancer or other cancers linked to a CDH1 gene mutation. The goal was to see if the treatment could shrink tumors and to check for side effects. While both drugs had…
Matched conditions: LOBULAR BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
Gene study reveals hidden breast cancer risks in young women
Knowledge-focused CompletedThis study looked at 421 women with lobular breast cancer to see how often they have changes in the CDH1 gene. The goal was to understand if these gene changes raise the risk for breast cancer, especially in women diagnosed at a young age or with cancer in both breasts. The resea…
Matched conditions: LOBULAR BREAST CARCINOMA
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated May 16, 2026 23:46 UTC